Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
Clinical trial NCT04051606 · COMPLETED
Trial details
- NCT number
- NCT04051606
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-31
- Primary completion
- 2024-03-20
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.